Hall Susan 4
4 · Valeant Pharmaceuticals International, Inc. · Filed Oct 4, 2012
Insider Transaction Report
Form 4
Hall Susan
Global Head of R&D
Transactions
- Tax Payment
Common Stock, no par values
2012-10-04−8,672→ 13,424 total
Footnotes (2)
- [F1]This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of Performance Share Units on September 26, 2012.
- [F2]This number represents common shares purchased by the officer, common shares received upon settlement and/or exercise of previously granted equity awards, as well as other outstanding equity awards that were previously reported in Table 1.